Imaging-based assessment of sarcopenia is essential for developing personalized management strategies in pancreatic disease. By utilizing imaging techniques, healthcare providers can accurately evaluate muscle mass and quality, which are critical indicators of patient prognosis. As the understanding of sarcopenia's impact on treatment outcomes continues to evolve, establishing standardized protocols will be vital for improving patient care and optimizing therapeutic interventions in pancreatic diseases.